https://www.selleckchem.com/pr....oducts/Vorinostat-sa
Current asthma guidelines recommend stepping down controller treatment when the condition is well-controlled for a certain time. However, the optimal step-down strategy for well-controlled patients receiving a low-dose inhaled corticosteroid (ICS) with a long-acting β -agonist (LABA) remains unclear. This study was a randomized, open-label, three-arm, parallel pragmatic trial comparing two kinds of step-down approaches for maintaining treatment. Adults with asthma who were aged 18 years or older, and who had been stable with low
Like
Comment
Share
